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Dopaminergic Haplotype as a Predictor
of Spatial Inattention in Children
With Attention-Deficit/Hyperactivity Disorder
Mark A. Bellgrove, PhD; Katherine A. Johnson, PhD; Edwina Barry, MD; Aisling Mulligan, MD;
Ziarah Hawi, PhD; Michael Gill, PhD; Ian Robertson, PhD; Christopher D. Chambers, PhD
Context: A distinct pattern of selective attention defi-
cits in attention-deficit/hyperactivity disorder (ADHD)
has been difficult to identify. Heterogeneity may reflect
differences in underlying genetics.
Objective: To document an objective deficit of selec-
tive attention in a large sample of children with and with-
out ADHD using spatial orienting paradigms. By strati-
fying samples according to the gene dosage of a risk
haplotype of the dopamine transporter gene (DAT1), we
could determine whether genetic factors predict spatial
inattention in ADHD.
Design: A case-control design was used.
Setting: Children with ADHD were recruited from clin-
ics or support groups in Ireland. Typically developing chil-
dren were recruited from schools in and around Dublin,
Ireland.
Participants: One hundred fifteen children were re-
cruited (ADHD=50, control=65). Groups were matched
for age but differed in estimated intelligence.
Intervention: Two versions of a visual spatial orient-
ing task in which attention was directed by valid, neu-
tral, or invalid cues to target locations. Sudden-onset pe-
ripheral cues (exogenous) and centrally presented
predictive cues (endogenous) were used.
MainOutcomeMeasures: To isolate an attention defi-
cit in ADHD, groups were first compared using analysis
of variance on the spatial orienting tasks. Multiple re-
gression was used to assess the main effect of DAT1 hap-
lotype status (heterozygous vs homozygous) and the in-
teraction of diagnosis and genotype on those variables
that discriminated children with and without ADHD.
Results: Children with ADHD displayed deficits in re-
orienting attention from invalidly cued spatial loca-
tions, particularly for targets in the left visual field.DAT1
haplotype status predicted spatial reorienting deficits for
left visual field targets (P=.007) but there was also a sig-
nificant interaction of diagnosis and genotype (P=.02),
which revealed the greatest impairment in children with
ADHD homozygous for the DAT1 haplotype.
Conclusion: Heterogeneity in selective attention in ADHD
can be explained by a replicated genetic risk factor for
ADHD, the 10/3 DAT1 haplotype.
Arch Gen Psychiatry. 2009;66(10):1135-1142
C LINICAL DESCRIPTIONS OFchildren with attention-deficit/hyperactivity disor-der (ADHD) as being inat-tentive and distracted by
extraneous stimuli in the environment
suggest a deficit of selective attention. Se-
lective attention refers to those cognitive
processes that facilitate the processing of
task-relevant stimuli and suppress the pro-
cessing of task-irrelevant stimuli. In the spa-
tial domain, selective attention serves to en-
hance the processing of stimuli at attended,
vs unattended, locations in space. How-
ever, confirmation of an attentional deficit
using objective methods from cognitive sci-
ence has proven elusive,1 leading to selec-
tive attention being de-emphasized within
contemporary accounts of ADHD.2-4 Herein,
we show that deficits of spatial selective at-
tention are apparent in ADHD and are pre-
dicted by a frequent haplotype of the dopa-
mine transporter gene (DAT1), a replicated
genetic risk factor for ADHD.
Within cognitive science, spatial selec-
tive attention is often probed using vari-
ants of the covert visual orienting task, de-
veloped by Posner and colleagues.5,6 In
visual orienting tasks, cues predict the spa-
tial location of an upcoming target stimu-
lus either correctly (valid cue), incorrectly
(invalid cue), or uninformatively (neu-
trally cued trials). These tasks yield several
reaction time (RT) effects that are indica-
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tive of spatial selection. First, when attention is cued val-
idly to a target location, RTs are typically faster than when
the target is preceded by a neutral cue. This RT benefit re-
flects the attentional enhancement of perceptual process-
ing at validly cued locations. In contrast, the disadvantage
or cost in RT conferred by invalid cues, relative to either
neutral or valid cues, reflects the time taken to reorient at-
tention from the invalidly cued location to detect a target
in an uncued location. Additionally, 2 modes of visual ori-
enting can be distinguished. Stimulus-driven or exog-
enous mechanisms can be probed using salient peripheral
cues that capture attention. In contrast, strategic or endog-
enous mechanisms can be probed by building expectancy
across trials using a centrally presented stimulus (eg, ar-
rowhead) that cues attention on most occasions.7
Human lesion, neurodisruption, and functional
imaging work have helped to define the neural sub-
strates of spatial orienting and reorienting.8,9 Broadly
speaking, tasks in which attention is strategically allo-
cated to a spatial location activate a bilateral network of
brain regions that has been conceptualized as forming a
dorsal frontoparietal network.7 This network is thought
to comprise the frontal eye fields and the dorsal poste-
rior parietal cortex along the intraparietal sulcus. Acti-
vation foci in the basal ganglia and cerebellum have also
been observed for endogenous orienting.10 This bilat-
eral dorsal frontoparietal network may be contrasted with
a right-lateralized ventral frontoparietal network that in-
cludes the inferior frontal gyrus and temporoparietal junc-
tion.7 Classically, patients with lesions to the right pari-
etal lobe have difficulty reorienting their attention from
invalidly cued locations in the right hemifield to detect
targets in the left hemifield.5 That is, these patients dis-
play an ipsilesional orienting bias and contralesional re-
orienting deficit.
Several lines of evidence suggest dopaminergic
modulation of spatial attention. First, dopamine ago-
nists modulate behavioral indexes of visual spatial ori-
enting in healthy subjects11 and reduce the extent of
neglect in right-hemisphere patients.12 Second, experi-
mental lesions of ascending dopaminergic pathways in
rodents induce a spatial neglect for the contralesional
side.13 Deficits in spatial orienting14 and attentional
biases have also been observed in patients with Parkin-
son disease, particularly those with greater dopamine
loss in the right striatum.15
A number of studies have now applied spatial orient-
ing tasks to the study of selective attention in ADHD.16
Although the results from these studies have proven
inconclusive, a number of studies have noted asym-
metrical performance of the participants with ADHD,
such that they performed more poorly than controls in
one visual field. Epstein et al17 noted increased cuing
costs for left visual field targets in ADHD. Nigg et al18
and McDonald et al19 noted slowed responses in the left
visual field for uncued targets. Increased cuing costs for
left targets may be indicative of a right-hemisphere
reorienting deficit whereas slowed responses to uncued
left targets could reflect a right-hemisphere arousal defi-
cit.20 Studies using other selective attention paradigms
have also described left-sided impairments.21 Neverthe-
less, a number of studies using visual orienting tasks
have either failed to document group differences,
observed reduced rather than increased costs for left
targets,22 or observed increased costs for right targets.23
Inconsistencies between studies likely reflect differ-
ences in methods but also the well-documented neuro-
psychological heterogeneity of ADHD.24 Herein, we sought
to determine whether inconsistencies could be clarified
by stratifying children according the presence of a fre-
quent haplotype of the dopamine transporter gene
(DAT1). Allelic variation in DAT1 is a replicated genetic
risk factor for ADHD, and a common haplotype com-
prising the 10-repeat and 3-repeat alleles of 2 variable
number of tandem repeat polymorphisms (VNTRs) within
this gene is thought to increase risk for the disorder.25,26
No studies have yet established the functional signifi-
cance of this haplotype for cognition in ADHD. In a pre-
vious report, we demonstrated an influence of DNA vari-
ants of DAT1 on exogenous spatial attention in healthy
control children.27 If neuropsychological heterogeneity
in ADHD reflects differences in underlying genetics, then
spatial attention deficits, including the reorienting of at-
tention between the visual fields, should be most pro-
nounced in those children with ADHD with a higher gene
dosage of the DAT1 haplotype.
METHODS
PARTICIPANTS
One hundred fifteen children participated in this study
(ADHD=50, control=65). Clinical and demographic data can
be found in Table 1. Data from 51 healthy control children
on the exogenous orienting task have been presented previ-
ously.27 Children with ADHD were referred by psychiatrists or
recruited via support groups in Ireland. A subset of the ADHD
group had previously participated in studies linking variation
inDAT1 to clinical measures of spatial bias (eg, line bisection).28,29
All participants with ADHD met DSM-IV diagnoses for ADHD,
as determined through semistructured interviews by psychia-
trists using the parent form of the Child and Adolescent Psy-
chiatric Assessment30 or the Parental Account of Childhood
Symptoms.31 Forty-four (88%) of the children met criteria for
ADHD predominantly combined type and 6 (14%), for ADHD
predominantly inattentive type. The frequency of opposi-
tional defiant disorder was 32% and conduct disorder, 8%. Ex-
clusion criteria included known neurological conditions or per-
vasive developmental disorders, serious head injuries, and lower
than average intelligence (70 on a short form of the Wechs-
ler Intelligence Scale for Children III that included Block De-
sign, Information, Picture Completion, and Vocabulary). Con-
trol children were also excluded if they had first-degree relatives
with ADHD. Handedness was measured using the Edinburgh
Handedness Inventory.32
The parents of all children also completed the Conners’
ADHD Rating Scale–Revised: Long or Short versions at the time
of cognitive testing. Control children had Conners’ Global In-
dex t scores of 60 or less. To facilitate the inclusion of as many
participants with ADHD as possible, we did not apply an in-
clusion cutoff for Conners’ ratings (eg, t65). Nevertheless,
the majority of the participants had Conners’ Global Index
t scores of 65 or more (n=43) and 7 had Global Index t scores
less than 65 (range across ADHD cohort, 52-90). Given ro-
bust evidence for an association between reading disorder and
spatial attention impairment,33 participants scoring in the clini-
cal range (1.5 SDs lower than the mean of the reading sub-
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test) of the Wide Range Achievement Test were also excluded
(Table 1). Any stimulant medication was withdrawn at least
24 hours prior to the neuropsychological testing. Details re-
garding the medication history of the participants with ADHD
can be found in Table 2.
Informed consent was provided according to the approved
requirements of Trinity College Dublin and the Dublin Mid Lein-
ster Health Service executive ethics committees.
SPATIAL ORIENTING TASKS
Participants performed both an exogenous and endogenous re-
flexive orienting task across separate sessions, each lasting ap-
proximately 11⁄2 hours (Figure 1). In both tasks, participants
used a joystick to indicate whether a target stimulus appeared at
an upper (forward response) or lower (backward response) lo-
cation, irrespective of whether it occurred on the left or right.27
In the exogenous task, participants performed 384 trials in which
the target was preceded by a peripheral cue that occurred on the
same (valid, 33%) or opposite (invalid, 33%) side as the target or
in the case of the neutral cue (33%), on both sides (Figure 1A).
The stimulus onset asynchrony (SOA) between the cue and tar-
get events was randomly either 200 or 800 milliseconds.
In the endogenous task, arrowheads presented above and
below fixation (300 milliseconds) indicated the likely spatial
location of an upcoming target (Figure 1B). Sixty percent of
the trials were validly cued, allowing participants to strategi-
cally speed their response to this cue. Twenty percent of trials
were neutrally cued (double-headed arrowheads providing no
spatial cue) and 20% were invalid. To reduce the temporal pre-
dictability of each trial, the cue-target SOA was randomly either
500 or 700 milliseconds. Participants performed 320 trials. Both
tasks were performed in a counterbalanced order, with eye move-
ments monitored on a trial-by-trial basis. Trials on which a sac-
cade occurred were excluded from analysis.
GENOTYPING
Genomic DNA was extracted from blood or saliva using Ora-
gene DNA Self-Collection Kits (DNA Genotek Inc, Ottawa, On-
tario, Canada). Polymerase chain reaction amplification of the
intron 8 marker was performed as described in our previous
report.27 Polymerase chain reaction amplification and geno-
typing of the 3 untranslated region (UTR) VNTR was con-
Table 1. Clinical and Demographic Data for the ADHD and Control Participants
Mean (SD)
Significance Test P Value
ADHD
(n=50)
Controls
(n=65)
Male, No. 42 61 2 = 0.3 .57
Right-handed, No. 44 57 2 = 1.9 .37
Age, y 13.3 (1.7) 13.7 (2) t113 = 1.1 .05
IQ 99 (13) 111 (13) t113 = 4.9 .05
WRAT reading score 96 (12) 108 (13) t113 = 5.3 .05
WRAT spelling score 93 (13) 108 (14) t113 = 5.9 .05
Conners’ ADHD Index score 74 (8) 45 (7) t113 = 20.8 .05
Conners’ Global Index score 77 (10) 46 (5) t113 = 21.5 .05
Conners’ DSM-IV Inattentive score 73 (9) 45 (7) t113 = 18.9 .05
Conners’ DSM-IV Hyperactive/Impulsive score 79 (12) 47 (5) t113 = 20.1 .05
Conners’ DSM-IV Total score 78 (9) 46 (6) t113 = 22.8 .05
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; WRAT, Wide Range Achievement Test.
Table 2. Medication History for the Participants With ADHD
Type of Medication
No. of Children
With ADHD
Medicated
Medication
Dose, mg,
Range
Concerta 15 18-72
Ritalin 6 10-30
Ritalin SR 3 30-40
Strattera 1 NA
Dexedrine 1 7.5
Concerta and risperidone 1 72 and 1
Previously but not currently medicated 9 . . .
Never medicated 14 . . .
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ellipses, not
applicable; NA, not available; SR, slow release.
A Exogenous B Endogenous
Fixation (500 ms)
Cue (100 ms)
Blank
(100 or 700 ms)
Target (100 ms)
Fixation (500 ms)
Cue (300 ms)
Blank
(200 or 400 ms)
Target (100 ms)
Figure 1. Task schematics of the exogenous (A) and endogenous (B) covert
visual orienting paradigms. In both tasks, participants fixated on a central
point (500-millisecond duration) that turned from gray to yellow to signal the
commencement of a trial. Each display included 4 black placeholders (2.1°
diameter) that were positioned 13.3° to the left or right and 3.6° above and
below fixation. Thereafter, attention was cued exogenously via a luminance
increase in the peripheral placeholders (100 milliseconds; 100% contrast) or
endogenously via predictive arrowheads presented above and below fixation
(300 milliseconds). The target stimulus was a 100-millisecond sine-wave
grating that occurred with equal probability within the upper or lower
placeholder of the left or right visual field. Participants identified the vertical
location of the target (upper or lower) as rapidly as possible using a joystick,
irrespective of whether the target occurred on the left or right. This
orthogonal cuing procedure enables mechanisms of spatial attention to be
assessed independently of any potentially confounding effects of response
selection or response bias.34 Stimulus onset asynchronies were randomly
either 200 or 800 milliseconds for the exogenous task and 500 or 700
milliseconds for the endogenous task.
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ducted as described by Cook et al.35 Genotypes within the ADHD
and control cohorts across each of the 3 UTR and intron 8
VNTRs were in Hardy-Weinberg equilibrium (ADHD: 3UTR,
2=0.35; P .05; intron 8, 2=0.03; P .05; control: 3 UTR,
2=1.77; P .05; intron 8, 2=0.05; P .05). Linkage disequi-
librium between the 2 markers was calculated in the control
sample as (D) 0.77.
DAT110/3 haplotype status was assigned to participants using
a Bayesian approach to reconstructing haplotypes imple-
mented in the program PHASE version 2.02.36 Haplotypes were
determined for 84 participants (31 ADHD; 53 control; prob-
ability0.9). Sixteen (53%) of the participants with ADHD were
homozygous for the 10/3 haplotype, whereas 14 (45%) were
heterozygous. One participant with ADHD did not possess the
10/3 haplotype. Sixteen (30%) of the healthy control children
were homozygous and 29 (55%) were heterozygous for the 10/3
haplotype. Eight control children (16%) did not possess the 10/3
haplotype. For statistical analysis, participants were grouped
as possessing two 10/3 haplotypes or fewer than two 10/3 hap-
lotypes. A 2 analysis confirmed a significant association be-
tween DAT1 10/3 haplotype status and diagnosis (21=4.69;
P=.03; odds ratio, 1.79 [95% confidence limit, 1.06, 3.02]). The
frequency of the 10/3DAT1 haplotype was 76% and 65% within
ADHD and control cohorts, respectively. There was no influ-
ence of 10/3 haplotype status on IQ in children with ADHD
(F1,29 = 0.007; P .05) or typically developing children
(F1,51=1.18; P .05). Nor was there an interaction between di-
agnosis and DAT1 genotype for IQ (F1,80=0.37; P .05). In-
creasing gene dosage of the 10/3 haplotype was associated with
increasing symptoms (n=84; Connors’ DSM-IV Inattention:
r=0.27; P=.01; Connors’ DSM-IV Total: r=0.25; P=.02; Con-
nors’ ADHD Index: r=0.28; P=.01). The direction of these ef-
fects was consistent in both children with and without ADHD.
STATISTICAL ANALYSES
A 2-step approach to statistical analysis was undertaken. First,
we sought to confirm a spatial attention deficit in the ADHD
group, relative to controls, independent of genetic effects. Re-
action time data were submitted to mixed-model analyses of
variance (ANOVAs), with task factors as repeated measures and
diagnosis as a between-subjects factor. The benefit of valid spa-
tial cues for perception was assessed relative to neutrally cued
trials (benefits). The cost to perception of invalid spatial cues
was assessed relative to both a valid (validity effect) and neu-
tral cue baseline (costs). Preliminary analyses showed no in-
teractions between diagnosis and critical task factors for error
rates or variability of RT. We therefore present mean RT re-
sults for correct responses only. Because cuing effects at the
short and longer SOAs in the exogenous paradigm may not be
directly comparable, we analyzed mean RT at each SOA sepa-
rately. Although the SOA manipulation in the endogenous cu-
ing paradigm was primarily designed to provide temporal jit-
ter, SOA was nonetheless analyzed as a factor. Because cuing
costs typically increase with SOA in endogenous cuing tasks,37
the longer SOA might provide greater sensitivity to detect group
differences than the shorter SOA. Second, we sought to deter-
mine the relationship between DAT1 genotype and those spe-
cific cognitive indexes that discriminated children with ADHD
and controls, thus reducing the potential for type I error. Mul-
tiple regression determined whether DAT1 10/3 haplotype sta-
tus (2 copies vs 2 copies) accounted for unique variance in
attentional indexes over and above that attributed to IQ and
diagnosis. The interaction term (diagnosisDAT1 haplotype
status) was included to determine whether deficits were par-
ticularly pronounced in the subset of children with ADHD who
were homozygous for the 10/3 haplotype. Although geno-
types at both the 3 UTR and intron 8 VNTRs were available,
analyses focused on the 10/3 haplotype to (1) further reduce
the potential for multiple comparisons and because (2) the hap-
lotype should carry more information regarding the locus of
any causative variant than either marker alone.
RESULTS
CHILDREN WITH ADHD DISPLAY
SPATIAL ATTENTION DEFICITS
Exogenous Cuing Effects
RT: 200-Millisecond SOA. Reaction time data were sub-
mitted to a diagnosissidecue ANOVA, with IQ co-
varied. Significance levels for analyses without IQ co-
varied are also presented for comparison purposes for key
effects. A significant main effect of diagnosis (F1,112=29.9;
P=.001) was observed, which reflected slower RTs of the
children with ADHD (mean [SE], 588 [14] millisec-
onds) compared with controls (mean [SE], 486 [12] mil-
liseconds). There was a significant main effect of target
side (F1,112=5.023; P=.03), which reflected slower re-
sponses to targets in the left visual field (mean [SE], 540
[9] milliseconds) relative to targets on the right (mean
[SE], 533 [8] milliseconds). There was also a significant
main effect of cue (F2,224=4.595; P=.01). Responses on
invalid trials (mean [SE], 544 [9] milliseconds) were
slower than on neutral trials (mean [SE], 529 [8] milli-
seconds; P=.001) and tended to be slower than on valid
trials (mean [SE], 538 [9] milliseconds;P=.09). Valid trials
were slower than neutral trials (P=.008). The slower re-
sponses to invalid, relative to neutral, cues permitted the
calculation of cuing costs. Since responses to valid trials
were slower than to neutral trials, cuing “benefits” must
be interpreted with caution.
A significant interaction was observed between diag-
nosis, target side, and cue (F2,224=3.06;P .05). This effect
was also significant without IQ covaried (P .05). As
shown in Figure 2, children with ADHD exhibited sig-
nificantly higher cuing costs for left targets than did con-
trol children (F1,112=5.4;P .05); however, cuing costs did
not differ for right targets (F1,112=0.39; P=.54). Cuing ben-
efits for right targets differed between the groups
(F1,112=5.034; P=.03), being positive for the ADHD group
and negative for the control children. A negative cuing ben-
efit for the control children indicates that, on average, the
control children did not accrue a performance benefit from
valid spatial cues. There were no differences in cuing ben-
efits for left targets (F1,112=0.63; P=.43). The earlier-
mentioned effects for cuing benefits were driven by asym-
metrical responses in the ADHD group to validly cued trials
(F1,112=5.76;P=.02): Children with ADHD responded more
slowly to validly cued left, relative to right, targets (P=.001),
whereas no such asymmetry existed for control children
(P=.30). Neither the children with ADHD nor control chil-
dren displayed asymmetrical responses to neutrally cued
trials (F1,112=0.89; P .05).
RT: 800-Millisecond SOA. At the 800-millisecond SOA,
there was no main effect of cue (F2,224=0.016;P=.98). There
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was, however, a main effect of diagnosis (F1,112=27.5;
P=.001) and a diagnosiscue interaction (F2,224=5.26;
P=.006), which reflected a greater effect of cues in the chil-
dren with ADHD than controls (P=.002 without IQ co-
varied). Cuing costs were higher in the ADHD group (mean
[SE], 14 [3] milliseconds) than in controls (mean [SE], 3
[3] milliseconds) (F1,112=6.07; P .02), as was the valid-
ity effect (invalid RT−valid RT) (ADHD: mean [SE], 12 [4]
milliseconds; controls: mean [SE], −5 [4] milliseconds)
(F1,112=8.433; P .005)]. The results for the control chil-
dren at the 800-millisecond SOA were as expected: at a
longer cue-target delay, attention shifts away from the cued
location, resulting in less cost to perception of invalid cues.38
In contrast, even at the longer SOA, children with ADHD
demonstrated increased cuing costs and higher validity ef-
fects, suggesting that attention shifted from the cued loca-
tion more slowly. Cuing costs and the validity effect cor-
related with each other (r=0.47; P=.001), suggesting that
both measures index a common spatial reorienting mecha-
nism.Therewerenodifferencesbetween thegroups in terms
of cuing benefits (F1,112=1.2; P .05).
Endogenous Cuing Effects: RT
Of the total sample of 115 children, data on the endog-
enous orienting task were available for 49 children with
ADHD and 63 control children. Mean RT data were sub-
mitted to a diagnosis target sidecueSOA mixed-
model ANOVA. In addition to a main effect of diagnosis
(F1,109=45.57; P .001), there was a diagnosis target
sidecue interaction (F2,218=3.04; P=.05) (P=.09 with-
out IQ covaried). Costs, benefits, and the validity effect
were calculated over SOA as a function of target side. There
was a significant interaction between diagnosis and tar-
get side for the validity effect (invalid RT−valid RT;
F1,109=5.5; P=.02) (P=.04 without IQ covaried). This was
driven by the larger validity effect for left targets (mean
[SE], 44 [5] milliseconds) relative to right targets (mean
[SE], 28 [6] milliseconds) in the children with ADHD
(P=.007), but not in controls (left: mean [SE], 26 [5] mil-
liseconds; right: mean [SE], 30 [6] milliseconds) (P .05).
Further, validity effects for left targets were greater in the
children with ADHD compared with the control chil-
dren (P=.02). There was no interaction between diag-
nosis and target side for cuing costs (invalid RT−neutral
RT; F1,109= 1.31; P .05) or cuing benefits (neutral
RT−valid RT; F1,109=2.01; P .05).
There was also a significant interaction between diag-
nosis, cue, and SOA (F2,218=3.8; P .05). Costs, benefits,
and the validity effect were compared as a function of di-
agnosis and SOA, collapsing across target side. Diagnosis
andSOAdidnotinteractforcuingcosts(F1,109=2.01;P.05)
or benefits (F1,109=2.5;P .05). There was a significant in-
teraction between diagnosis and SOA for the validity effect
(F1,109=6.03;P=.02)(P=.06withoutIQcovaried)(Figure3).
Children with ADHD had significantly higher validity ef-
fects at the 700-millisecond SOA (mean [SE], 47 [6] mil-
liseconds), comparedwithcontrols (mean[SE],27[6]mil-
liseconds) (P=.03). Further, validity effects increased as a
function of SOA in the ADHD group (P=.002), but not in
controls (P=.73). This effect was driven by a significant in-
teraction between diagnosis and SOA for invalid RTs
(F1,109=5.58; P=.02), but not for valid RTs (F1,109=0.67;
P .05). Reaction time differences between children with
ADHDandcontrolchildren for invalid trials increasedwith
SOA as a result of an increase in RT for the children with
ADHD,andadecrease inRTforcontrolchildren,overSOA.
Taken together, compared with validly cued trials, the
children with ADHD were slower to reorient attention
to targets in the left, relative to right, visual field and
showed increased validity effects for left targets than con-
trol children. Irrespective of lateral effects, group differ-
ences in invalid RT were maximal at the longer SOA.
DOPAMINERGIC HAPLOTYPE PREDICTS
SPATIAL INATTENTION IN ADHD
Exogenous Cuing Effects
DAT1 10/3 haplotype status accounted for significant vari-
ance in cuing costs for targets in the left, but not right,
visual field at the 200-millisecond SOA (Table 3). Di-
agnosis and DAT1 interacted: cuing costs for left visual
field targets were highest in children with ADHD who
were 10/3 DAT1 homozygotes (Figure 4).
Although there was no association betweenDAT1 10/3
haplotype status and cuing costs at the 800-millisecond
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Figure 2. Mean cuing cost (invalid reaction time−neutral reaction time) as a
function of target side and diagnosis at the 200-millisecond stimulus onset
asynchrony for the exogenous cuing task. ADHD indicates
attention-deficit/hyperactivity disorder.
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Figure 3. Mean validity effect (invalid reaction time−valid reaction time) as a
function of stimulus onset asynchrony (SOA) and diagnosis for the endogenous
cuing task. ADHD indicates attention-deficit/hyperactivity disorder.
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SOA, there was a trend for an interaction between diag-
nosis and DAT1 genotype. Calculating cuing costs over
SOA yielded both an effect of DAT1 genotype and an in-
teraction of diagnosis and DAT1 genotype.
Endogenous Cuing Effects
At the 500-millisecond SOA, there was neither a main
effect ofDAT1haplotype status nor an interaction ofDAT1
and diagnosis. At the 700-millisecond SOA, however, there
was a significant interaction between DAT1 and diagno-
sis. Validity effects were highest in the children with
ADHD who were homozygous for the DAT1 10/3 hap-
lotype (Figure 5).
COMMENT
Past studies of spatial orienting in ADHD have yielded
equivocal results. To our knowledge, this study has
presented the largest ADHD-control comparison in
children yet, using the covert visual orienting task.
Across exogenous (stimulus-driven) and endogenous
(strategic) forms of the task, children with ADHD
were slower than control children in redirecting their
attention from invalid cues presented in the visual
field opposite to the target. This reorienting deficit
was particularly pronounced for left visual field tar-
gets, suggesting dysfunction to right-hemisphere spa-
tial attention systems. Yet despite these overall group
differences, neuropsychological heterogeneity was evi-
dent in the ADHD cohort and predicted by variation in
a frequent haplotype of DAT1. Children with ADHD
who had a higher gene dosage of the 10/3 DAT1 hap-
lotype displayed pronounced deficits across measures
but were particularly impaired in reorienting attention
to detect targets in the left visual field at short (200-
millisecond) SOAs. Our results provide the first evi-
dence, to our knowledge, that a frequent (10/3) haplo-
type of DAT1 has a functional effect on cognitive
performance in ADHD.
The results of the current study show that children with
ADHD experience difficulty in reorienting attention, in-
dicative of impairment in spatial selection. In the exog-
enous task, this deficit was evident across SOAs and at longer
SOAs for the endogenous task. In both tasks, however, in-
teractions with cue validity were further modified by higher-
order effects involving target side. For the exogenous task
at the 200-millisecond SOA, cuing costs in the ADHD group,
Table 3. Regression Analyses Examining the Influence of DAT1 Haplotype Status on Key Attentional Indexesa
Attention Index Effect F Test P Value R 2 Change, % B Value SE  95% CLb
Exogenous 200-ms SOA
Left cuing cost DAT1 7.6 .007 8.5 20.7 7.5 0.3 5.8, 35.6
Diagnosis  DAT1 5.4 .02 5.8 −34.5 14.8 −0.97 −64.0, −5.0
Right cuing cost DAT1 0.32 .05 0.4 4.4 7.7 0.06 −10.9, 19.7
Diagnosis  DAT1 0.85 .05 1.1 −14.4 15.6 −0.42 −45.5, 16.7
Exogenous 800-ms SOA
Cuing cost DAT1 1.7 .05 1.9 6.5 5.1 0.14 −3.5, 16.6
Diagnosis  DAT1 3.3 .07 3.6 −18.3 10.1 −0.77 −38.4, 1.8
Validity effect DAT1 0.05 .05 0.1 −1.5 6.5 −0.02 −14.5, 11.5
Diagnosis  DAT1 0.52 .05 0.6 9.5 13.3 0.32 −16.9, 36.0
Exogenous over SOA
Cuing cost DAT1 5.6 .02 6.2 9.5 4.0 0.26 1.5, 17.6
Diagnosis  DAT1 7.4 .008 7.5 −21.4 7.9 −1.1 −37.1, −5.7
Endogenous 500-ms SOA
Validity effect DAT1 0.02 .05 0.0 0.97 8.1 0.14 −15.1, 17.03
Diagnosis  DAT1 0.44 .05 0.6 −10.9 16.4 −0.31 −43.6, 21.8
Endogenous 700-ms SOA
Validity effect DAT1 2.6 .05 3.1 13.4 8.3 0.18 −3.15, 29.9
Diagnosis  DAT1 4.3 .04 4.9 67.67 27.48 0.91 12.9, 122.4
Endogenous over SOA
Left validity effect DAT1 0.009 .05 0.0 0.69 7.3 0.11 −13.9, 15.2
Diagnosis  DAT1 0.005 .05 0.5 −8.9 14.9 −0.28 −38.5, 20.7
Abbreviations: CL, confidence limit; SE, standard error; SOA, stimulus onset asynchrony.
aMultiple regression, controlling for diagnosis and IQ, was used to test the association of the DAT1 10/3 haplotype with those attentional indexes that most
discriminated children with attention-deficit/hyperactivity disorder and control children. Interactive effects of diagnosis and DAT1 genotype were also tested.
bOf the unstandardized B values.
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Figure 4. Mean cuing cost (invalid reaction time−neutral reaction time) for
targets in the left and right visual field at the 200-millisecond stimulus onset
asynchrony for the exogenous task as a function of diagnosis
(attention-deficit/hyperactivity disorder [ADHD], controls) and DAT1
haplotype status (low or high risk) (low risk=heterozygous for 10/3
haplotype; high risk=homozygous for 10/3 haplotype).
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relative to controls, were greater for left-sided targets. The
ability of the current study, relative to past studies, to de-
tect lateralized group differences may be partly attribut-
able to increased trial numbers with an attendant reduc-
tion in error variance, exclusion of potentially confounding
comorbid reading impairments,33 and exclusion of trials on
which a saccade was made.
Our lateralized results imply dysfunction to the poste-
rior orienting system that is dominant in the right hemi-
sphere and resemble effects reported in patients with le-
sions to the right parietal cortex.5 Similarly, our findings
of increased cuing costs in children with ADHD at the 800-
millisecond SOA, although not lateralized, suggest a slug-
gish posterior reorienting mechanism in ADHD.17,22 Other
studies using a variety of selective attention paradigms have
also found evidence of left-sided impairment in ADHD, in-
dicative of disruption to right-hemisphere posterior atten-
tional systems.21,39,40 Recent brain imaging work also sug-
gests an important role for the right parietal cortex in both
the pathology41 and clinical outcome associated with
ADHD.42 In the current study, children with ADHD were
also slower to reorient attention to endogenously cued tar-
gets in the left visual field relative to a valid trial baseline.
This finding is comparable with that reported previously
in adults with ADHD17 and may suggest additional involve-
ment of frontostriatal systems implicated in the volitional
control of attention.10 Taken together, the results of the pres-
ent study suggest a broad disruption to right-hemisphere
spatial attention systems in ADHD.
Neuropsychological heterogeneity in ADHD is present
across multiple cognitive domains24 and likely explains the
failure of a number of studies to document selective atten-
tion deficits in ADHD. We sought to dissect this hetero-
geneity by asking whether a common haplotype of DAT1
predicted spatial attention deficits in ADHD. At the short
(200-millisecond) SOA for the exogenous cuing task,DAT1
haplotype status (2 copies vs2 copies) accounted for 8.5%
variance in cuing costs for left visual field targets.27 Impor-
tantly, however, there was also an interaction between di-
agnosis and DAT1 haplotype: children with ADHD who
were also homozygous for the high-risk DAT1 haplotype
had the most significant impairment in reorienting atten-
tion overall and in particular to targets in the left visual field
(5.8% variance). A similar interaction, albeit of smaller effect
size (4.9% variance), was observed for endogenous cuing
costs at the longer SOA. These effect sizes are of similar
magnitude to those reported between working memory and
COMT genotype (4%), for example.43 Our findings repre-
sent the first evidence, to our knowledge, that a common
haplotype of DAT1 is a predictor of neuropsychological
heterogeneity in ADHD. The largely intact performance of
children with ADHD who were heterozygous for the hap-
lotype may help to explain why previous studies of selec-
tiveattention inADHDmighthave failed todocumentgroup
differences, particularly in relatively small samples. Al-
though there have been isolated reports that DAT1 vari-
ants also influence other cognitive domains, such as vigi-
lance and response time variability, in participants with
ADHD,44,45 a number of studies have failed to document
an effect of DAT1 on neurocognitive function in ADHD
when using executive and motoric measures.46 The cur-
rent results are, however, consistent with our previous ob-
servations in the Irish population that parietal-dependent
measuresof attentional asymmetryareassociatedwithDAT1
variation and predict stimulant response in ADHD.28,29
The association between DAT1 and spatial selective
attention, particularly for the exogenous orienting task,
implies dopaminergic modulation of posterior atten-
tional systems, including the parietal cortex. The pari-
etal cortex receives strong dopaminergic input47 and dopa-
mine transporter immunohistochemistry in the posterior
parietal cortex has been reported.48 Yet our results run
counter to work suggesting cholinergic modulation of spa-
tial selective attention. Cholinergic agonists such as nico-
tine reduce the costs of invalid spatial cues in human sub-
jects and the cholinergic antagonist scopolamine increases
cuing costs in nonhuman primates.49 However, an inter-
action between these systems seems likely since cholin-
ergic agonists promote dopamine signaling.50 Further-
more, nicotine may bind to the dopamine transporter,
mimicking the effect of methylphenidate and increasing
dopamine reuptake.51 Future studies should therefore in-
vestigate this potentially important pharmacological in-
teraction and its effects on spatial selective attention.
Taken together, the results of this study demonstrate
that DNA variation in a risk haplotype for ADHD pre-
dicts spatial inattention in ADHD. Heterogeneity in the
extent of selective attention deficit across individuals with
ADHD may reflect, in part, genetic differences.
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Figure 5. Mean validity effect (invalid reaction time−valid reaction time) at
the long (700-millisecond) stimulus onset asynchrony in the endogenous
cuing task as a function of diagnosis (attention-deficit/hyperactivity disorder
[ADHD], controls) and DAT1 haplotype status (low or high risk) (low
risk=heterozygous for 10/3 haplotype; high risk=homozygous for 10/3
haplotype).
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